Crohn's disease trials in China

In China 73 Also abroad 424

20 of 73 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Prediction of Postoperative Recurrence in Crohn's Disease
Where
Guangzhou
Age
18 years to 70 years
People
250
Run by
Sixth Affiliated Hospital, Sun Yat-sen University
See details and how to joinNCT07824791
No phaseTaking people
Exclusive Enteral Nutrition Therapy for Active and Complicated Crohn's Disease
Where
Guangzhou
Age
18 years and over
People
300
Run by
Sixth Affiliated Hospital, Sun Yat-sen University
See details and how to joinNCT07504510
No phaseTaking people
Comparison of the Efficacy of Different Biologic Agents in Preventing Postoperative Endoscopic Recurrence of Crohn's Disease
Where
Shanghai
Age
18 years to 85 years
People
198
Run by
Shanghai 10th People's Hospital
See details and how to joinNCT07694674
No phaseTaking people
Real-World Study of IL-23 Inhibitors in Active Crohn's Disease
Where
Guangzhou
Age
18 years to 75 years
People
665
Run by
Sixth Affiliated Hospital, Sun Yat-sen University
See details and how to joinNCT07545317
No phaseTaking people
IBD Biomarker Discovery and Validation Platform
Where
Guangzhou
Age
14 years and over
People
6,000
Run by
Sixth Affiliated Hospital, Sun Yat-sen University
See details and how to joinNCT07686406
No phaseTaking people
Clinical Value of Intestinal Ultrasound in Predicting Clinical Relapse in Crohn's Disease Patients in Deep Remission: a Multicenter Prospective Observational Study
Where
Guangzhou
Age
18 years to 70 years
People
420
Run by
Nanfang Hospital, Southern Medical University
See details and how to joinNCT07539727
No phaseNot yet taking people in China
An Observational, Multicenter Study to Evaluate the Effectiveness of Guselkumab for the Treatment of Participants With Crohn's Disease After Surgical Resection
Where
Shanghai
Age
18 years and over
People
88
Run by
Shanghai 10th People's Hospital
See details and how to joinNCT07528040
No phaseTaking people
A Prospective Observational Study on the Efficacy and Safety of Guselkumab in the Treatment of Crohn's Disease Patients Previously Treated With Ustekinumab
Where
Hangzhou
Age
18 years to 75 years
People
60
Run by
Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07487480
No phaseTaking people
Guselkumab Vs Ustekinumab in Stricturing Crohn's Disease
Where
Hangzhou
Age
18 years to 80 years
People
100
Run by
Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07444060
No phaseTaking people
Efficacy of Ustekinumab Therapy in Patients With Symptomatic Stricturing Crohn's Disease
Where
Beijing, Chongqing, Guangzhou, Hangzhou, Huai'an, Suzhou, Yangzhou
Age
18 years to 65 years
People
239
Run by
Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT05387031
No phaseTaking people
Prophylactic Dexamethasone Before Infliximab in Moderate-to-Severe IBD
Where
Hangzhou
Age
14 years to 80 years
People
300
Run by
Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07385131
No phaseTaking people
Epidemiological Characteristics and Efficacy Evaluation of Difficult-To-Treat Crohn's Disease
Where
Guangzhou
Age
18 years to 65 years
People
1,400
Run by
Xiang Gao
See details and how to joinNCT07364734
No phaseTaking people
Real-World Study on Fecal Microbiota Transplantation: Long-Term Effectiveness and Safety Statistics
Where
Shanghai
Age
3 years and over
People
4,000
Run by
Chen QiYi
See details and how to joinNCT07261826
No phaseTaking people
AI-Assisted MRE for Intestinal Fibrosis in Crohn's Disease
Where
Guangzhou, Hangzhou, Huangpu, Nanjing
Age
18 years to 75 years
People
234
Run by
Minhu Chen
See details and how to joinNCT06858553
No phaseTaking people
Value of IUS in Predicting Vedolizumab Efficacy and Assessing Transmural Healing in Early Crohn's Disease: A Multicenter, Prospective Study
Where
Changsha
Age
18 years to 80 years
People
60
Run by
The Third Xiangya Hospital of Central South University
See details and how to joinNCT07093294
No phaseTaking people
IUS Predicts Guselkumab Efficacy in Patients With Moderate to Severe Crohn's Disease：a Prospective Study
Where
Changsha
Age
18 years to 80 years
People
50
Run by
The Third Xiangya Hospital of Central South University
See details and how to joinNCT07034664
No phaseTaking people
Investigation of the Correlation Between Polyamine Levels and Their Key Enzymatic Activities in Association With Inflammatory Bowel Disease Progression
Where
Xi'an
Age
18 years to 65 years
People
146
Run by
Xijing Hospital
See details and how to joinNCT06995170
No phaseTaking people
Efficacy and Safety of Upadacitinib in Inflammatory Bowel Disease
Where
Guangzhou, Liuzhou, Meizhou, Nanning, Shenzhen
People
174
Run by
Xiang Gao
See details and how to joinNCT06780683
No phaseNot yet taking people in China
Individual Treatment of Ustekinumab in Perianal Fistulizing Crohn's Disease
Where
Wenzhou
Age
18 years to 65 years
People
119
Run by
Second Affiliated Hospital of Wenzhou Medical University
See details and how to joinNCT06739278
No phaseTaking people
Biologics for Stricturing Crohn's Diseases
Where
Nanjing
Age
16 years to 65 years
People
200
Run by
Jinling Hospital, China
See details and how to joinNCT05645055